시장보고서
상품코드
1604096

세계의 소양증 치료제 시장(2024-2028년)

Global Pruritus Drugs Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 157 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소양증 치료제 시장(2024-2028년)

소양증 치료제 시장은 2023-2028년 59억 달러 규모로 확대될 것으로 예상되며, 예측 기간 동안 7.1%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 소양증 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 면역요법의 인기 증가, 만성질환의 유병률 증가, 치료제의 인지도 향상 및 사용 증가로 인해 시장이 주도하고 있습니다.

시장 범위
기준 연도 2024년
종료 연도 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
전년 대비(2024년) 6.3%
CAGR 7.1%
증분 금액 59억 달러

이 보고서는 향후 몇 년 동안 소양증 치료제 시장의 성장을 촉진하는 주요 요인 중 하나로 새로운 치료 옵션의 출현을 꼽고 있습니다. 또한, 나노입자를 이용한 경피 약물전달 시스템 및 연구 자금의 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 밸류체인 분석

제3장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제4장 시장 규모 실적

  • 소양증 치료제 세계 시장(2018-2022년)
  • 용도별 분석(2018-2022년)
  • 지역별 분석(2018-2022년)
  • 국가별 분석(2018-2022년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 상황

제6장 시장 세분화 : 용도별

  • 시장 부문
  • 비교 : 용도별
  • 혈액성 소양증 : 시장 규모와 예측(2023-2028년)
  • 종양성 소양증 : 시장 규모와 예측(2023-2028년)
  • 신장 소양증 : 시장 규모와 예측(2023-2028년)
  • 내분비 소양증 : 시장 규모와 예측(2023-2028년)
  • 담즙울체성 소양증 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 용도별

제7장 고객 상황

  • 고객 상황 개요

제8장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 프랑스 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역별

제9장 촉진요인, 과제, 기회, 억제요인

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회·억제요인

제10장 경쟁 상황

  • 개요
  • 경쟁 상황
  • 혼란 상황
  • 업계 리스크

제11장 경쟁 분석

  • 기업 개요
  • 기업의 시장 포지셔닝
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Cara Therapeutics Inc.
  • GlaxoSmithKline Plc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roivant Sciences Ltd.
  • Sanofi SA

제12장 부록

ksm 24.12.12

Pruritus Drugs Market 2024-2028

The pruritus drugs market is forecasted to grow by USD 5.9 bn during 2023-2028, accelerating at a CAGR of 7.1% during the forecast period. The report on the pruritus drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing preference for immunotherapy, rising prevalence of chronic diseases, and increasing awareness and rising use of therapeutics.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.3%
CAGR7.1%
Incremental Value$5.9 bn

Technavio's pruritus drugs market is segmented as below:

By Application

    • Hematologic pruritus
    • Oncological pruritus
    • Renal pruritus
    • Endocrine pruritus
    • Cholestatic pruritus

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the emergence of novel treatment options as one of the prime reasons driving the pruritus drugs market growth during the next few years. Also, nanoparticle-enabled transdermal drug delivery systems and increasing research funding will lead to sizable demand in the market.

The report on the pruritus drugs market covers the following areas:

    • Pruritus Drugs Market sizing
    • Pruritus Drugs Market forecast
    • Pruritus Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus drugs market vendors that include AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol Myers Squibb Co., Cara Therapeutics Inc., Cipla Inc., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Ipca Laboratories, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, and Sun Pharmaceutical Industries Ltd.. Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Pruritus Drugs Market 2018 - 2022
    • Historic Market Size - Data Table on Global Pruritus Drugs Market 2018 - 2022 ($ billion)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ billion)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Hematologic pruritus - Market size and forecast 2023-2028
    • Chart on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
  • 6.4 Oncological pruritus - Market size and forecast 2023-2028
    • Chart on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oncological pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Oncological pruritus - Year-over-year growth 2023-2028 (%)
  • 6.5 Renal pruritus - Market size and forecast 2023-2028
    • Chart on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Renal pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Renal pruritus - Year-over-year growth 2023-2028 (%)
  • 6.6 Endocrine pruritus - Market size and forecast 2023-2028
    • Chart on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
  • 6.7 Cholestatic pruritus - Market size and forecast 2023-2028
    • Chart on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Application
    • Market opportunity by Application ($ billion)
    • Data Table on Market opportunity by Application ($ billion)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 8.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 8.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 8.11 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ billion)
    • Data Table on France - Market size and forecast 2023-2028 ($ billion)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
  • 11.4 Astellas Pharma Inc.
    • Astellas Pharma Inc. - Overview
    • Astellas Pharma Inc. - Product / Service
    • Astellas Pharma Inc. - Key offerings
  • 11.5 Cara Therapeutics Inc.
    • Cara Therapeutics Inc. - Overview
    • Cara Therapeutics Inc. - Product / Service
    • Cara Therapeutics Inc. - Key offerings
  • 11.6 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
  • 11.7 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
  • 11.8 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 11.9 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 11.10 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 11.11 Roivant Sciences Ltd.
    • Roivant Sciences Ltd. - Overview
    • Roivant Sciences Ltd. - Product / Service
    • Roivant Sciences Ltd. - Key offerings
  • 11.12 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
  • 12.9 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제